China clears agreement on vaccine co-production

Foreign minister Abdul Momen said China has sent the draft memorandum of understanding for co-production of its Sinopharm vaccine with a Bangladesh pharma.

“We have already sent the draft MoU to the health ministry … they should dispose it quickly,” he told reporters at State Guest House Padma on Tuesday. The foreign minister said it should not be delayed in preparing the final MoU as it would take two months to start coproduction here after signing the final agreement.

Momen confirmed that Chinese Sinopharm would go for co-production with Bangladeshi pharmaceutical company Incepta.

However, he said, as per the tentative agreement Incepta cannot produce the vaccine here, they will do only bottling and leveling of Chinese jabs locally. “It will also reduce the vaccine cost a lot,” Momen added.

The foreign minister said the final agreement would be signed among three parties – Bangladesh government, Incepta pharmaceutical and Chinese Sinopharm.

About co-reproduction of Russian vaccine here, the foreign minister said, currently the Moscow administrations is working slowly as Russia has been hit by the third wave of coronavirus.

“But we are after them (Moscow) with all our efforts (to make co-production of Russian vaccine here),” he said.

Earlier on Monday, Chinese ambassador to Bangladesh Li Jiming called on the foreign minister at his office.


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button